In all groups, the response against the BMLF1 A2 peptide was more

In all groups, the response against the BMLF1.A2 peptide was more frequent than that against the EBNA3C.A24 peptide (7 patients out of the possible 13, 3 aged-matched controls out of the possible 9 and 6 younger healthy c-Met inhibitor individuals out of the possible 7). Table 2 Number of EBV specific CTL amongst each group Subject group Mean ± Standard deviationa Rangea Young healthy individuals 24.3 ± 17.9 3.1 – 54.8 Aged healthy individuals 25.2 ± 17.2 10.4 – 53.9 Patients with lung cancer 21.8 ± 18.7 1.9 – 60.2 aValues represent number of EBV specific CTL amongst

one million peripheral CD8 T cells. In the process of determining the pCTL frequencies in the peripheral blood, we collected and evaluated flow cytometric data obtained from the analysis of each individual MLPCs. Interestingly, although MLPC containing a multimer positive population, amongst all three groups appeared to have similar multimer positive populations (Figure 2), interesting findings were observed when these were analysed

in detail. In particular, the mean percentage of multimer+CD8+ T cells inside the positive MLPCs was found significantly higher (p < 0.0001) in age-matched healthy subjects (26.6 ± 26.4%, range 0.4--80.7%) than in lung cancer patients (2.7 ± 3.3%, range 0.1-19.0%) and younger healthy individuals (2.4 ± 1.7%, range 0.2-7.0%) (Figure 3A). This reflects an increased proliferative capacity against the antigenic Alvocidib stimulus of the peptide-specific pCTLs in the older healthy subjects. On the other hand, no statistically significant difference was observed among the three groups with respect to the intensity of multimer binding by each multimer positive population (patients; MFI 6.9 ± 12.3, range 2-115, older healthy subjects; MFI 6.0 ± 4.1, range 2-23, younger healthy subjects; MFI 5.1 ± 3.7, range 2-19) (Figure 3B). This indicates that all antiviral T cells had TCR with a similar avidity towards the peptide/MHC complex and no difference in the kinetics

of interaction between TcR and multimer complexes could be observed [10]. Regarding the above, a significant correlation was observed between the percentage of multimer+CD8+ and the multimer MFI within the patient (r = 0.15, p < 0.0001) and the aged-matched healthy individual group (r = 0.504, p < 0.0001) but not within the young healthy individual group (r = 0.016, p = 0.435). Figure learn more 2 EBV multimer positive populations from patients, age-matched healthy individuals and healthy younger individuals. MLPC, were stained with test multimers folded with BMLF1.A2 or EBNA3C.A24 labelled with APC (y axis) and control multimers folded with irrelevant HLA-A2 or -A24 peptides labelled with PE (x axis). Each plot represents live CD8 lymphocytes with the multimer positive population indicated in each gate. Figure 3 Flow cytometric characteristics of circulating anti-EBV specific pCTL from patients, age-matched healthy individuals and healthy younger individuals.

Comments are closed.